Home › Funds › EA Series Trust › Altrius Global Dividend ETF
Fund family: EA Series Trust · Filed by EA Series Trust (CIK 1592900) · SEC series S000077499
Ticker: DIVD (C000237976)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 898 with, 61 against, 0 abstentions (not counted as with management); 5 items carried no recommendation. Shareholder proposals: 21 FOR, 41 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as EA Series Trust’s manager page (129,593 ballot items across 92 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | EA Series Trust | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 98.7% | 798 | 96.1% | 115,618 |
| Backed environmental and social shareholder proposals at US companies | n/a | 27 | 13.7% | 2,882 |
Each ballot item this fund voted is set against the votes of the other EA Series Trust funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most EA Series Trust funds on 2 items (0.3% of the 733 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most EA Series Trust funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| CONSTELLATION BRANDS, INC. | 2025-07-15 | Election of Director: Jennifer M. Daniels | For | AGAINST — 4 of 6 EA Series Trust funds | For | — |
| CONSTELLATION BRANDS, INC. | 2025-07-15 | Election of Director: William Giles | For | ABSTAIN — 4 of 6 EA Series Trust funds | For | — |
Download all 2 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 65.4% of this fund’s 959 such votes could be given a sector; the other 332 (34.6%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 143 | 11 | 7.7% |
| Industrials | 107 | 5 | 4.7% |
| Finance | 99 | 7 | 7.1% |
| Consumer Staples | 66 | 6 | 9.1% |
| Energy | 56 | 5 | 8.9% |
| Technology | 55 | 4 | 7.3% |
| Consumer Discretionary | 48 | 6 | 12.5% |
| Telecommunications | 28 | 4 | 14.3% |
| Real Estate | 13 | 0 | 0.0% |
| Basic Materials | 12 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 570 | 0 |
| Corporate Governance | 92 | 23 |
| Capital Structure | 67 | 0 |
| Audit-related | 62 | 0 |
| Say-on-Pay | 58 | 0 |
| Compensation | 44 | 2 |
| Other | 28 | 4 |
| Other Social Issues | 18 | 11 |
| Environment or Climate | 10 | 10 |
| Human Rights or Human Capital/workforce | 9 | 9 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| SANOFI | April 29, 2026 | $388,330 | 21 | 0 |
| BRITISH AMERICAN TOBACCO P.L.C. | April 15, 2026 | $354,744 | 19 | 0 |
| NOVARTIS AG | March 6, 2026 | $351,020 | 28 | 0 |
| GSK PLC | May 6, 2026 | $344,334 | 25 | 0 |
| BANCO BILBAO VIZCAYA ARGENTARIA S.A. | March 20, 2026 | $338,859 | 17 | 0 |
| PHILLIPS 66 | May 13, 2026 | $295,056 | 6 | 0 |
| UNITEDHEALTH GROUP INCORPORATED | June 1, 2026 | $282,261 | 12 | 1 |
| STATE STREET CORPORATION | May 20, 2026 | $276,194 | 16 | 1 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 1, 2026 | UNITEDHEALTH GROUP INCORPORATED | If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposal | For | Against |
| May 20, 2026 | STATE STREET CORPORATION | Shareholder proposal requesting the adoption of a policy and amendment to the by-laws requiring the Chair of the Board be an independent member of the Board in the next CEO transition, if properly presented. Shareholder proposal | Against | For |
| May 8, 2026 | ABBVIE INC. | Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposal | Against | For |
| May 26, 2026 | MERCK & CO., INC. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | MERCK & CO., INC. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| April 23, 2026 | JOHNSON & JOHNSON | Independent Board Chair Shareholder proposal | Against | For |
| May 19, 2026 | JPMORGAN CHASE & CO. | Report on congruence of security, resiliency, and climate initiatives Shareholder proposal | Against | For |
| May 19, 2026 | JPMORGAN CHASE & CO. | Independent board chairman Shareholder proposal | Against | For |
| April 30, 2026 | GILEAD SCIENCES, INC. | To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| April 30, 2026 | GILEAD SCIENCES, INC. | To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| May 27, 2026 | CHEVRON CORPORATION | Adopt an Independent Chair Shareholder proposal | For | Against |
| May 27, 2026 | CHEVRON CORPORATION | Report on Indigenous Peoples' Rights Shareholder proposal | Against | For |
966 ballot items at 60 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Altrius Global Dividend ETF (DIVD) voted at 60 shareholder meetings of 58 companies, on 966 ballot items in all. Where management made a recommendation, the fund followed it on 93.6% of the items and voted against it 61 times. Its most frequent area of disagreement was corporate governance (23 of its votes against management). It voted FOR 33.9% of the 62 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than EA Series Trust's funds as a whole (98.7% against 96.1%). It voted differently from most EA Series Trust funds on 2 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of EA Series Trust’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.